When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing–remitting multiple sclerosis

Kathleen Mary Noon, Stephen Maxwell Montgomery, Nicholas Edward Adlard, Nicholas Edward Adlard, Michel Anton Kroes
  • Journal of Medical Economics, July 2018, Taylor & Francis
  • DOI: 10.1080/13696998.2018.1491007

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/13696998.2018.1491007

The following have contributed to this page: Michel Kroes

In partnership with: